Literature DB >> 16784133

[Prevalence of metallo-beta-lactamase in carbapenem resistant Pseudomonas aeruginosa at a university hospital of Buenos Aires City].

G Pagniez1, M Radice, A Cuirolo, O Rodríguez, H Rodríguez, C Vay, A Famiglietti, G Gutkind.   

Abstract

The present study was conducted to estimate the prevalence of metallo-beta-lactamases in 91 consecutive carbapenem resistant Pseudomonas aeruginosa isolates, recovered from inpatients at Hospital de Clínicas in Buenos Aires. Both, phenotypic and genotypic methods detected the presence of carbapenemases in 10 (11%) isolates, corresponding to VIM-11 in 7/10 and VIM-2 in the others. Codifying genes were all included in class 1 integrons, upstream genes coding for aminoglycoside modifying enzymes. One hundred percent sensitivity and specificity was achieved by the metallo-beta-lactamases phenotypic screening method using EDTA (1 micromol) disks in the Pseudomonas aeruginosa isolates included in this study. Sensitivity to aztreonam in carbapenem resistant isolates was suspicious of the presence of these enzymes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16784133

Source DB:  PubMed          Journal:  Rev Argent Microbiol        ISSN: 0325-7541            Impact factor:   1.852


  2 in total

1.  Full Resistance and decreased susceptibility to carbapenems in IMP-13-producing Pseudomonas aeruginosa isolates from an outbreak.

Authors:  Gisela Santella; Arabela Cuirolo; Marisa Almuzara; Susana Palombarani; Gabriela Sly; Marcela Radice; Gabriel Gutkind
Journal:  Antimicrob Agents Chemother       Date:  2010-01-04       Impact factor: 5.191

2.  Spread of Clonally Related Escherichia coli Strains Harboring an IncA/C1 Plasmid Encoding IMP-8 and Its Recruitment into an Unrelated MCR-1-Containing Isolate.

Authors:  Alan Elena; Daniela Cejas; Francisco Magariños; Virginia Jewtuchowicz; Andrea Facente; Gabriel Gutkind; José Di Conza; Marcela Radice
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.